Home/ Supplements/ Omega 3/ Biomega-3 Liquid

Biomega-3 Liquid

product on market Liquid Biotics Research Corporation Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 25% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Omega-3 fatty acids are supported by strong evidence for promoting cardiovascular health and managing systemic inflammation. The ingredient profile focuses on essential fats, though overall evidence coverage for this specific formulation is limited. The product maintains a high safety profile for general consumption.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Biomega-3 Liquid
Open Full PDF View on NIH DSLD →
Details

Label Data

1 tsp
Serving Size
40
Servings
Fat/Fatty Acid
Product Type
25%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
40 {Calories}
Total Fat
4 g (6% DV)
Cholesterol
15 mg (5% DV)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)

Other Ingredients

Omega-3 Fish Oil natural Lemon flavor Rosemary extract Ascorbyl Palmitate natural tocopherols Ingredients
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

RECOMMENDATION: One (1) teaspoon each day as a dietary supplement or as otherwise directed by a healthcare professional.

Warnings & Precautions

KEEP OUT OF REACH OF CHILDREN

Additional Information

Keep container tightly sealed and store in a cool, dry area away from direct sunlight.

Rev. 11/09

Lot Number: 33730C Exp. Date: DEC 11

Metadata

Product Details

DSLD Entry Date2013-05-24
Product TypeFat/Fatty Acid
FormLiquid
DSLD ID21442
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.